Net profit of Cohance Lifesciences declined 76.01% to Rs 36.72 crore in the quarter ended December 2025 as against Rs 153.07 crore during the previous quarter ended December 2024. Sales declined 19.47% to Rs 544.55 crore in the quarter ended December 2025 as against Rs 676.23 crore during the previous quarter ended December 2024.
| Particulars | Quarter Ended |
| Dec. 2025 | Dec. 2024 | % Var. |
| Sales | 544.55 | 676.23 | -19 |
| OPM % | 17.51 | 35.10 | - |
| PBDT | 92.40 | 248.13 | -63 |
| PBT | 45.46 | 204.57 | -78 |
| NP | 36.72 | 153.07 | -76 |